13D/A filed by PharmaCyte Biotech, Inc.
PharmaCyte Biotech, Inc. reported 8,446,093 QCLS shares, 49.99% of the class, as of 2026-11-15, in a 13D/A accepted by EDGAR 2026-11-21 01:31:44 UTC.
- Accession
- 0001683168-26-009020
- Filer
- CIK 1157075
- Filed
- 2026-11-20
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Shares
- 8,446,093
- Percent of class
- 49.99%
- Event date
- 2026-11-15
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. | CO | 8,446,093 | 0 | 8,446,093 | 0 | 8,446,093 | 49.99% |